Hookipa Pharma Company

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Funding Status: IPO
Industry: Viral Vectors
Estimated Revenue: $1M to $10M
Headquarters: Vienna, Wien, Austria
Total Funding: 224284354
Last Funding Date: 2022-03-02
Last Funding Type: Post-IPO Equity
Employee Number: 51-100
Investors Number: 14
Founded Date: 2011-08-07